CIK: 1468534 - Address: C/O Novavax, Inc., 700 Quince Orchard Road, Gaithersburg, MD 20878
14 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
9/29/21 17:06
9/28/21
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagTrizzino JohnMDOEVP,CCO,S.d-1,575209.920-8-753D
9/29/21 17:04
9/27/21
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagTrizzino JohnMDOEVP,CCO,S.d-1,760234.610-8-753D
9/22/21 17:05
9/20/21
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagTrizzino JohnMDOEVP,CCO,S.dm-3,412227.470-15-951D
9/15/21 17:03
9/13/21
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagTrizzino JohnMDOEVP,CCO,S.dm-3,539235.950-15-951D
5/7/21 17:10
5/5/21
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagTrizzino JohnMDOEVP,CCO,S.dm-594184.940-3-920D
4/7/21 17:09
4/5/21
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagTrizzino JohnMDOEVP,ChieS.dm-608189.380-3-920D
3/9/21 19:38
3/5/21
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagTrizzino JohnMDOEVP,ChieS.dm-526163.740-3-920D
2/9/21 19:40
2/5/21
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagTrizzino JohnMDOEVP,ChieS.dm-941292.510-3-920D
1/27/21 18:10
1/25/21
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagTrizzino JohnMDOEVP,ChieS.a-9128.6000-200D
1/7/21 19:08
1/5/21
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagTrizzino JohnMDOEVP,CMO,S.dm-2,012112.340-18-980D
10/1/20 17:40
9/30/20
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagTrizzino JohnMDOEVP,CBO,S-248110.220-2-315D
9/30/20 21:28
9/28/20
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagTrizzino JohnMDOEVP,CBO,S.dm-4,723109.030-43-867D
8/20/20 18:25
8/18/20
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagTrizzino JohnMDOEVP,CBO,S.d-6,366148.780-43-895D
9/12/19 16:29
9/11/19
NVAXNovavax IncDEHealthBioPrdBiological Products, (No DiagTrizzino JohnMDOSVP,CBO,S-325.720-6-545D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact